RHB Retail Research says Duopharma Biotech Bhd may rebound further after it tested the MYR1.44 support in recent sessions.
In a trading stock note this morning, the research house says, as the stock marked a higher close vis-à-vis the previous sessions since 22 Apr, this indicates a positive sign.
An upbeat bias may emerge above the MYR1.51 level, with an exit set below the MYR1.44 mark.
Towards the upside, the immediate resistance is at the MYR1.67 level, followed by the MYR1.78 threshold.
